GENETRON HOLDINGS LIMITED Inactive Instrument
Genetron Holdings Limited
Equities
GTH
US37186H2094
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.025 USD | +0.12% |
|
+0.12% | +9.38% |
| Mar. 29 | Genetron Holdings Limited(NasdaqGM:GTH) dropped from NASDAQ Composite Index | CI |
| Mar. 28 | New Genetron Holding Limited completed the acquisition of Genetron Holdings Limited | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.
Calendar
2024-05-19
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -1.82% | 41.35B | |
| +42.55% | 40.38B | |
| +2.56% | 39.05B | |
| -12.11% | 26.67B | |
| +3.09% | 24.07B | |
| -24.16% | 18.36B | |
| +22.12% | 11.6B | |
| -3.74% | 11.68B | |
| +7.75% | 11.15B |
- Stock Market
- Equities
- GTH Stock
- News Genetron Holdings Limited
- Earlier US Stock Market Losses Weighed on Asian Equities
